https://www.unibestcn.com/en/news/viridian-lumvoa-thyroid-eye-disease-approval-2026
Viridian's Lumvoa Approval Reshapes Thyroid Eye Disease Market, Challenging Amgen's Tepezza |...
FDA approves Viridian Therapeutics' Lumvoa (veligrotug) for thyroid eye disease, creating the first direct competitor to Amgen's Tepezza with a differentiated...
thyroid eye diseaseviridianlumvoaapprovalreshapes